Omeprazole Cristers

Omeprazole, the active ingredient in Omeprazole Cristers, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults and children. GNH USA supplies Omeprazole Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazole Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumours. - Erosive esophagitis: aids mucosal healing in acid‑induced injury. - Helicobacter pylori eradication regimens (as adjunct): enhances effectiveness of antibiotic‑based therapy.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects: - Headache: mild, transient headache reported in clinical use. - Diarrhoea: loose stools occurring in a minority of patients. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: sudden kidney inflammation. - Severe hypersensitivity reactions: including rash, angioedema or anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Vitamin B12 deficiency: malabsorption with prolonged therapy. - Liver enzyme elevation: abnormal hepatic function tests.

When prescribing omeprazole, clinicians should consider several safety aspects.

- Assess renal and hepatic function: adjust use in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate need for long‑term therapy: weigh benefits against fracture risk. - Monitor for signs of infection: especially Clostridioides difficile. - Counsel on appropriate use: avoid unnecessary prolonged dosing. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, loss of antiviral efficacy. - Methotrexate (high dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, requires monitoring. - Phenytoin: may reduce plasma concentrations, adjust dose if needed. - Digoxin: possible increase in serum concentration, watch for toxicity.